Genzyme Europe

Biotechnology Research • Naarden, North Holland, Netherlands • 201-500 Employees

Company overview

Headquarters	Gooimeer 10, Naarden, None 1411 DD, NL
Website	sanofi.com
NAICS	541714
Founded	1981
Employees	201-500

Key Contacts at Genzyme Europe

Bert De Bruijn

Associate Director Accounts Payable

Anne-Marie Li-Kwai-Cheung

Director Eu Regulatory Affairs

Tracey Lodie

Senior Scientific Director

Ingrid Boltje Van Hooft

Medical Director Medical Affairs Cardiovascular Europe

Sue Graham

Director Medical Affairs

Steve Ponds

Ceo

Lemme Findout

Executive Director

Brenda Henson

Executive Director

Ajay Goyal

Shop Owner

潇潇刘

Joint Managing Director

Genzyme Europe Email Formats

Genzyme Europe uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@genzyme.com), used 61.9% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@genzyme.com	76.2%
{first name}.{last name}	john.doe@sanofi.com	23.8%

About Genzyme Europe

Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). LSDs remain the heart of our company today, but we have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis. Driven by our commitment to patients, we strive to develop strong relationships with patient communities and listen to their perspectives so that we can truly understand their needs. These collaborations guide us as we continue to push the boundaries of medicine and technology to develop new and better therapies where none existed before.

Genzyme Europe revenue & valuation

Annual revenue	$23,800,000
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$76,200,000
Total funding	No funding

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Entry

Manager

Director

Employees by Department

Genzyme Europe has 126 employees across 15 departments.

Departments

Number of employees

Funding Data

Genzyme Europe has never raised funding before.

Frequently asked questions

Genzyme Europe is located in Naarden, North Holland, NL.

Genzyme Europe was founded in 1981, making it 45 years old. The company has established itself as a significant player in its industry over this time.

Genzyme Europe has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.